Analytical performance and method comparison of the Elecsys PIVKA-II immunoassay as an aid in diagnosis of hepatocellular carcinoma (HCC)

Home / Key Publications / Biomarkers / Analytical performance and method comparison of the Elecsys PIVKA-II immunoassay as an aid in diagnosis of hepatocellular carcinoma (HCC)

You May Also Like

Dr Bing Liu featured image

Expert Opinions

20 January 2025

Screening for Liver Cancer at Zhuhai People’s Hospital

Expert Opinions

16 January 2025

Current Trends in Liver Fibrosis Etiology and Diagnosis

Expert Opinions

16 January 2025

HKASLD Consensus Recommendations: PIVKA-II for the surveillance and monitoring of HCC in Hong Kong

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.